Use of biologic agents and risk of tuberculosis in Brazil, a tuberculosis high-burden country

Use of biologic agents and risk of tuberculosis in Brazil, a tuberculosis high-burden country

Background: Brazil is a country with a high burden of tuberculosis (TB). The immunomodulatory effect of biological therapies is associated with an increased risk of infection. This study evaluated the frequency of TB infection in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS),...

Full description

Bibliographic Details
Main Authors: Fernanda Gomes Gonçalves Chaer, Juliana Miranda de Lucena Valim, Rogério Castro Reis, Giselle Burlamaqui Klautau, Branca Dias Batista de Souza
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2020-07-01
Series:Drugs in Context
Subjects:
biological therapy
immunomodulation
latent
tuberculosis
tumor necrosis factor inhibitors
Online Access:ttps://www.drugsincontext.com/use-of-biologic-agents-and-risk-of-tuberculosis-in-brazil,-a-tuberculosis-high-burden-country

Internet

ttps://www.drugsincontext.com/use-of-biologic-agents-and-risk-of-tuberculosis-in-brazil,-a-tuberculosis-high-burden-country

Similar Items